Recommendations for the prevention, diagnosis, and treatment of osteonecrosis of the jaw (ONJ) in cancer patients treated with bisphosphonates.
Bagán
José
J
Valencia School of Medicine, Valencia, Spain. Jose.V.Bagan@uv.es
Blade
Juan
J
Cozar
Jose Manuel
JM
Constela
Manuel
M
García Sanz
Ramón
R
Gómez Veiga
Francisco
F
Lahuerta
Juan José
JJ
Lluch
Ana
A
Massuti
Bartomeu
B
Morote
Juan
J
San Miguel
Jesús F
JF
Solsona
Eduardo
E
D004164:Diphosphonates / Q000009:adverse effects* / Q000627:therapeutic use; D006801:Humans; D007571:Jaw Diseases / Q000139:chemically induced* / Q000175:diagnosis / Q000517:prevention & control / Q000628:therapy; D009369:Neoplasms / Q000188:drug therapy; D010020:Osteonecrosis / Q000139:chemically induced* / Q000175:diagnosis / Q000517:prevention & control / Q000628:therapy; D017410:Practice Guidelines as Topic
D004164:Diphosphonates